Megan Nicole Mcclary, PA-C Internal Medicine - Medical Oncology Medicare: Medicare Enrolled Practice Location: 81 Wagner Rd, Monaca, PA 15061 Phone: 724-671-1500 |
Dr. Matthew Paul Sniezek, D.O Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 79 Wagner Rd, Monaca, PA 15061 Phone: 724-773-1926 |
Nicole Marie Maietta, CRNP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3942 Brodhead Rd, Monaca, PA 15061 Phone: 724-773-1994 |
Dr. Benjamin Alberto Laracuente, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3468 Brodhead Rd Ste 11, Monaca, PA 15061 Phone: 724-728-5995 Fax: 724-728-6705 |
Dr. Atac Turkay, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 79 Wagner Rd, Monaca, PA 15061 Phone: 724-773-1928 Fax: 724-770-7924 |
Dr. William Joseph Rust, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 79 Wagner Rd, Monaca, PA 15061 Phone: 724-773-1926 |
News Archive
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.
At any given moment, millions of cells are on the move in the human body, typically on their way to aid in immune response, make repairs, or provide some other benefit to the structures around them. When the migration process goes wrong, however, the results can include tumor formation and metastatic cancer. Little has been known about how cell migration actually works, but now, with the help of some tiny worms, researchers at the California Institute of Technology (Caltech) have gained new insight into this highly complex task.
The age-old fascination with machines mimicking humans has frequently manifested itself in science fiction literature and cinema, mainly because authors and directors could only wildly speculate about these "human robots" since none had been built yet. According to bionic limb experts at IEEE, the world's largest professional technical association, the distinction between science fiction and reality is increasingly becoming blurred.
Celgene International Sàrl today announced that its next IMiD compound, pomalidomide, was evaluated in three separate investigational trials of patients with multiple myeloma who were relapsed or refractory after prior treatments including lenalidomide, thalidomide and bortezomib. The clinical data were presented at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida.
› Verified 7 days ago